Test Directory

Hepatitis B Surface Antigen

Loinc

Expected Turnaround

24 hours

Information

Assay results may be used as an aid in the determination of susceptibility to hepatitis B virus (HBV) infection for individuals prior to or following HBV vaccination, or where vaccination status is unknown. Assay results may be used with other HBV serological markers for the laboratory diagnosis of HBV disease associated with HBV infection. A reactive assay result will allow a differential diagnosis in individuals displaying signs and symptoms of hepatitis in whom etiology is unknown.

Collection Information

Methodology

Electrochemiluminescence-immunoassay (ECLIA)

Limitations

Assay performance characteristics have not been established for the use of the Elecsys Anti‑HBs assay as an aid in determining susceptibility to HBV infection prior to or following vaccination in infants, children, or adolescents.

Rejection Criteria

Specimen Stability

Refrigerated: 6 days Frozen: 3 Months

Alias

Hepatitis B Surface Antigen; HBsAg; Qualitative HBV surface antigen; HBV

Container Type

Serum, gel separator, SST

Minimum Volume

1 ML

Age Range

0 - 999

Sex

Generic

Units of Measure

COI

Reference Range

Panic Range